Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature
Sign Up to like & getrecommendations! Published in 2022 at "Experimental Biology and Medicine"
DOI: 10.1177/15353702211069986
Abstract: Metformin is one of the most prescribed drugs in the world giving potential health benefits beyond that of type 2 diabetes (T2DM). Emerging evidence suggests that it may have protective effects for retinal/posterior segment diseases… read more here.
Keywords: preclinical clinical; clinical studies; studies insights; metformin retinal ... See more keywords
Engineering Cell Therapies for Autoimmune Diseases: From Preclinical to Clinical Proof of Concept
Sign Up to like & getrecommendations! Published in 2022 at "Immune Network"
DOI: 10.4110/in.2022.22.e37
Abstract: Autoimmune diseases are caused by a dysfunction of the acquired immune system. In a subset of autoimmune diseases, B cells escaping immune tolerance present autoantigen and produce cytokines and/or autoantibodies, resulting in systemic or organ-specific… read more here.
Keywords: cell; autoimmune diseases; engineering cell; therapies autoimmune ... See more keywords